Orthopedic Research Funding: Assessing the Relationship between Investments and Breakthroughs
- PMID: 38993375
- PMCID: PMC11236838
- DOI: 10.52965/001c.120368
Orthopedic Research Funding: Assessing the Relationship between Investments and Breakthroughs
Abstract
Orthopedic research plays a crucial role in improving patient outcomes for musculoskeletal disorders. This narrative review explores the intricate interplay between funding patterns and the trajectory of breakthroughs achieved in this dynamic field. A meticulous search strategy identified studies illuminating the diverse sources of orthopedic research funding, including public funding (government agencies), philanthropic organizations, private sector investment, and international funding bodies. The review further delved into the spectrum of breakthroughs, encompassing fundamental scientific discoveries, technological advancements, and personalized medicine approaches. Public funding emerged as a significant pillar, supporting foundational research that lays the groundwork for future advancements. Philanthropic organizations addressed specific musculoskeletal disorders, often focusing on patient-centric applications. International funding bodies played a role in supporting research in low- and middle-income countries. Breakthroughs extended beyond cutting-edge prosthetics and minimally invasive surgeries, encompassing fundamental discoveries in areas like gene therapy and biomaterials science. Technological advancements included brain-computer interface prosthetics and 3D-printed implants. Personalized medicine offered the potential for tailored treatments based on individual needs and genetic profiles. This review underscores the complex interplay between funding patterns and breakthroughs in orthopedic research. A multifaceted approach is essential for continued progress. Fostering collaboration, optimizing funding models, and prioritizing both foundational and translational research hold the key to unlocking the true potential of orthopedic research and transforming the lives of patients suffering from musculoskeletal disorders.
Keywords: Biomaterials science; Brain-computer interface; Fundamental discoveries; Funding patterns; Orthopedic research; Philanthropic organizations; personalized medicine; public funding.
Conflict of interest statement
All conflicts of interest have been identified, and there has been no significant financial support or funding for this work that could have influenced its outcome.
Similar articles
-
Global funding for surgical research between 2016 and 2020: content analysis of public and philanthropic investments.Br J Surg. 2025 May 31;112(6):znaf089. doi: 10.1093/bjs/znaf089. Br J Surg. 2025. PMID: 40458936 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.Lancet Oncol. 2023 Jun;24(6):636-645. doi: 10.1016/S1470-2045(23)00182-1. Lancet Oncol. 2023. PMID: 37269844
-
Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine.J Pers Med. 2024 Jun 4;14(6):598. doi: 10.3390/jpm14060598. J Pers Med. 2024. PMID: 38929819 Free PMC article. Review.
-
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.J Clin Med. 2024 Jul 8;13(13):3977. doi: 10.3390/jcm13133977. J Clin Med. 2024. PMID: 38999541 Free PMC article. Review.
References
-
- Network structure of the human musculoskeletal system shapes neural interactions on multiple time scales. Kerkman J. N., Daffertshofer A., Gollo L. L., Breakspear M., Boonstra T. W. Jun 27;2018 Sci Adv. 4(6):eaat0497. doi: 10.1126/sciadv.aat0497. doi: 10.1126/sciadv.aat0497. - DOI - DOI - PMC - PubMed
-
- Gene Therapy in Orthopaedics: Progress and Challenges in Pre-Clinical Development and Translation. Watson-Levings R. S., Palmer G. D., Levings P. P., Dacanay E. A., Evans C. H., Ghivizzani S. C. 2022Frontiers in bioengineering and biotechnology. 10:901317. doi: 10.3389/fbioe.2022.901317. doi: 10.3389/fbioe.2022.901317. - DOI - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources